The discrepant effect of FRMD3 protection in c22 nephropathy homozygotes, versus risk in non-c22 nephropathy homozygotes, raised the possibility that the T2DM-ESRD case group contained subsets of cases with different diseases. This evidence concerns the gene FRMD3 and Nephropathy.